In the presence of ERb, trans-hydroxytamoxifen (TOT) protects cells against 17b-estradiol (E 2 )-induced oxidative DNA damage (ODD) and this correlates with increased expression of the antioxidative enzyme quinone reductase (QR). Here, we investigate the molecular mechanism responsible for ERb-mediated protection against ODD. We observe constitutive interaction between ERb and the novel protein hPMC2. Using a combination of breast epithelial cell lines that are either positive or negative for ERa, we demonstrate TOT-dependent recruitment of both ERb and hPMC2 to the EpRE (electrophile response element)-regulated antioxidative enzyme QR. We further demonstrate TOT-dependent corecruitment of the coactivators Nrf2, PARP-1 (poly (ADP-ribose) polymerase 1) and topoisomerase IIb, both in the presence and absence of ERa. However, absence of either ERb or hPMC2 results in nonrecruitment of PARP-1 and topoisomerase IIb, loss of antioxidative enzyme induction and attenuated protection against ODD by TOT even in the presence of Nrf2 and ERa. These findings indicate minor role for Nrf2 and ERa in TOT-dependent antioxidative gene regulation. However, downregulation of PARP-1 attenuates TOT-dependent antioxidative gene induction. We conclude that ERb and hPMC2 are required for TOTdependent recruitment of coactivators such as PARP-1 to the EpRE resulting in the induction of antioxidative enzymes and subsequent protection against ODD.
Introduction
Prolonged exposure to estrogen is strongly associated with increased risk for developing breast cancer (Bolton and Thatcher, 2008) . Metabolism of estrogens in breast epithelial cells generates highly reactive catechol estrogen quinones (CE-Q) that form mutagenic DNA adducts. Further, the interconversion of quinonesemiquinone forms generates reactive oxygen species, which induce oxidative stress inside the cells (Cavalieri et al., 2006) . The sustained oxidative stress, together with the mutagenic potential of CE-Qs contributes to the initiation and progression of breast cancer (Liehr, 2000) . This hypothesis is strengthened by our observation that downregulation of the antioxidative enzyme quinone reductase (QR), coupled with exposure to 17b-estradiol (E 2 ) leads to the increased levels of CE-Q and transformation of nontumorigenic breast epithelial cells (Montano et al., 2007) . QR catalyzes the reduction of estradiol-3,4-quinone, thus preventing the generation of reactive oxygen species by quinone-semiquinone interconversion . Also, a strong correlation exists between breast cancer incidence and polymorphisms in several antioxidative genes including NQO1, indicating an important role for antioxidative enzymes in breast cancer prevention and treatment (Menzel et al., 2004; Oestergaard et al., 2006; Sakoda et al., 2007; Udler et al., 2007) .
We observed that QR expression is increased in mammary glands of rats treated with tamoxifen and this increased expression correlates with a decrease in E 2 -induced ODD (oxidative DNA damage) levels (Montano et al., 2007) . Also, treatment of human breast epithelial cells with trans-hydroxytamoxifen (TOT) prevents E 2 -induced increase in CE-Q levels (Montano et al., 2007) . This ODD protective ability of tamoxifen makes it an attractive candidate for chemoprevention of breast cancer. In fact, the recently concluded Study of Tamoxifen and Raloxifene (STAR) and International Breast Cancer Intervention Study (IBIS) breast cancer trials highlight the advantage of using tamoxifen and raloxifene as chemopreventive agents (Fabian, 2007; Jordan, 2007) .
TOT treatment increases the activity of reporter genes regulated by an EpRE (electrophile response element) sequence (Montano et al., 2004) . EpRE is a cis-regulatory element present in the upstream of many antioxidative gene promoters including GCSH, GSTP1 and NQO1 (Rushmore et al., 1991; Tew, 1994; Prestera and Talalay, 1995; Strange et al., 2001) . GSTpi (glutathione-S-transferase pi) detoxifies CE-Qs by conjugation with the cellular antioxidant glutathione, while GCSh (g glutamylcysteine synthase heavy subunit) catalyzes the rate-limiting step in the de novo synthesis of glutathione (Liehr, 2000) . EpRE-regulated reporter genes are activated by TOT-ERb (estrogen receptor b), but not significantly by TOT-ERa (estrogen receptor a), and the ODD protective ability of TOT is not observed in the absence of ERb (Bianco et al., 2003; Montano et al., 2004) . These data indicate a key for TOT-ERb in mediating oxidative stress response through the regulation of EpRE promoters.
The role of tamoxifen in regulating ERa-dependent transcription is well characterized, but mechanism of ERb-mediated transcription in breast cancer cells is not well defined. Even less is known about the pathway responsible for TOT-ERb-mediated upregulation of EpRE-regulated genes. Hence, our goal in the current study was to analyze TOT-mediated events at the EpRE locus and thereby define the transcription coactivator complex responsible for ERb-dependent upregulation of EpRE genes.
Results
The ERb-interacting protein, hPMC2 is important for tamoxifen-mediated protection against estrogen-induced oxidative DNA damage TOT-induced transcription of EpRE genes is further enhanced by the ERb-interacting protein hPMC2 (prevention of mitotic catastrophe; Montano et al., 2000) , suggesting a role for hPMC2 in TOT-mediated protection against ODD. So, we transiently downregulated the expressions of both hPMC2 and QR ( Figure 1a ) by retroviral infection, and immunostained for 8-OHdG to analyze the relative roles of hPMC2 and QR in mediating TOT-dependent protection against E 2 -induded ODD in response to TOT.
Cells expressing knockdown levels of either hPMC2 or QR displayed higher basal levels of ODD compared with control-infected cells, while E 2 treatment resulted in greater than twofold increase in the ODD levels of all three cell lines (hPMC2 shRNA, QR shRNA, control shRNA) (Figure 1b) . Treatment with TOT alone revealed 8-OHdG levels lesser than or similar to that of the ethanol-treated samples, indicating that TOT by itself does not contribute to ODD. Knockdown of QR did not result in a complete loss of the protective ability of TOT, in confirmation with our previous observations (Bianco et al., 2003) . This finding suggests the contribution of other antioxidative enzymes (GSTpi, GCSh and so on) in mediating the ODD protective ability of TOT. However, in hPMC2 knockdown cells 8-OHdG levels were similar to that of the E 2 -treated samples even with the TOT treatment, indicating a requirement for hPMC2 in TOT-ERb-mediated protection against E 2 -induced ODD.
In vitro studies indicate the selective interaction of hPMC2 with ERb. (Montano et al., 2000) . Immunoprecipitation of MCF7 lysates for unliganded, E 2 -liganded and TOT-liganded ERb resulted in coimmunoprecipitation of hPMC2 in all three cases. Conversely, hPMC2 immunoprecipitation pulled down ERb both in the presence and absence of E 2 or TOT, indicating constitutive interaction between ERb and hPMC2 ( Figure 1c ). Taken together, our data indicate a novel role for hPMC2 in TOT-mediated protection against ODD by selective interaction with ERb to induce antioxidative gene expression.
Tamoxifen treatment results in the recruitment of ERb, hPMC2 and transcriptional coactivators to the EpRE ERb and hPMC2 interact in vivo and hPMC2 together with ERb binds to the EpRE sequence in vitro (Montano et al., 2000) . These data suggest potential recruitment of ERb and hPMC2 to the EpRE regions in vivo. To test the TOT-dependent recruitment of these (b) MCF7 cells transiently infected with retroviral particles to knockdown QR and hPMC2 expression were treated for 24 h with 0.01% ethanol, 50 nM E 2 or 100 nM TOT or a combination of E 2 and TOT as indicated. Cells were immunostained with an antibody against 8-OHdG and the intensity of the staining quantitated in each case. The bars represent the average of three independent experiments and the standard error is given by the error bars. *Represents Po0.001 vs the E 2 -treated samples. (c) Serum-starved MCF7 cells were treated with either 0.01% ethanol (con), 10 nM E 2 or 10 nM TOT for 3 h. Lysates were immunoprecipitated using antibodies against ERb or hPMC2 and analyzed for coimmunoprecipitating proteins by western blotting. Normal rabbit immunoglobilin was used as a specificity control. Input lanes represent 25% of the total protein. ChIP, chromatin immunoprecipitation; ER, estrogen receptor; ODD, oxidative DNA damage; QR, quinone reductase; TOT, trans-hydroxytamoxifen.
Tamoxifen-dependent transcription of EpRE genes SP Sripathy et al proteins, we used chromatin immunoprecipitation (ChIP) to analyze the EpRE region of the NQO1 gene ( Figure 2a) . We treated the cells for 3 h with the indicated ligands, as that was the earliest time point at which we observed transcriptional induction (data not shown). To identify other factors involved in ERbmediated induction of EpRE, we first studied the recruitment of known ERa-associated transcriptional coactivators: SRC-1 (steroid receptor coactivator-1), PARP-1 (poly (ADP-ribose) polymerase 1) and topoisomerase IIb (Shang and Brown, 2002; Ju et al., 2006) . We also tested for the recruitment of the EpRE-binding transcriptional activator Nrf2 (NF-E2-related factor-2) (Venugopal and Jaiswal, 1996) .
We observed weak recruitment of PARP-1 and Nrf2 in control-treated samples but a strong recruitment of all the factors tested in the TOT-treated cells indicating a predominantly TOT-dependent recruitment of not only ERb, hPMC2 and Nrf2, but also ERa-associated coactivators (Figures 2b and c) . Analysis of TOTtreated samples revealed little or no recruitment of any of the proteins tested either at B800 bp upstream of the EpRE or at the NQO1 promoter region located B400 bp downstream to the EpRE (Figure 2d ), suggesting a localized and selective recruitment to the EpRE region.
An initial ChIP of the TOT-treated samples with an antibody to hPMC2, followed by reimmunoprecipitation of the chromatin using antibodies to the indicated proteins confirmed mutual recruitment of ERb, hPMC2 Nrf2, ERa and ERa-associated coactivators to the EpRE (Figure 2e ). Taken together, the data indicate that TOT-ERb together with hPMC2, recruits an ERa-like activation complex localized to the EpRE region, resulting in transcriptional induction.
ERb and hPMC2 are required for effective inhibition of estrogen-induced oxidative DNA damage by tamoxifen To examine the ERa-independent role of ERb and hPMC2 in TOT-mediated induction of EpRE and in protection against E 2 -induced ODD, we used the ER negative, nontumorigenic breast epithelial cell line, MCF10A (Montano et al., 2007) . The lack of ERa ChIP analysis of TOT-treated cells for recruitment of the indicated factors using primers upstream and downstream of the EpRE region (e) MCF7 cells were treated with 10 nM TOT for 3 h and processed lysates were subjected to ChIP using an antibody against hPMC2 (rabbit IgG was used as a specificity control). hPMC2-precipitated chromatin was diluted 1:20 and reimmunoprecipitated using the indicated antibodies. The precipitates were then used to isolate DNA and subjected to PCR analysis at the EpRE locus. The results in each case are representatives of two or more independent experiments. ChIP, chromatin immunoprecipitation; EpRE, electrophile response element; IgG, immunoglobulin G; TOT, transhydroxytamoxifen.
Tamoxifen-dependent transcription of EpRE genes SP Sripathy et al expression enabled us to examine the ability of ERb and hPMC2 to recruit ER-associated coactivators and for inducing antioxidative genes in the absence of ERa. We established two MCF10A cell lines, both of which constitutively express Flag-ERb (FL-ERb), and one of them expresses stably knocked down levels of hPMC2 (hPMC2mi; Figure 3a ). No significant change was observed in expression levels of QR, GCSh and GSTpi upon TOT treatment of MCF10A(P) cells (Figure 3b ). In contrast, a twofold to threefold increase in the expression of all three enzymes in FL-ERb stables was observed, indicating that the transcriptional induction by TOT requires ERb. Also, no significant changes were observed in antioxidative enzyme expression levels upon TOT treatment of hPMC2mi cells, strongly suggesting a requirement for hPMC2 in this process (Figure 3b ). Similar results were obtained when the cell lines were tested for the ability of TOT to protect against E 2 -induced ODD (Figure 3c ). The protective ability of TOT was severely attenuated in the absence of either ERb or hPMC2.
We also measured the effect of E 2 treatment on the levels of catechol estrogens and their quinone conjugates in the presence and absence of TOT (Figure 3d ). We measured the levels of 4-hydroxyestradiol-quinone conjugate (4-con) as this metabolite is predominantly responsible for the formation of mutagenic DNA adducts (Li et al., 2004) . Following E 2 -treatment, we observed comparable levels of 4-con induction in MCF10A(P) and FL-ERb cells, while cells downregu- Figure 3 Both ERb and hPMC2 are required for tamoxifen-mediated increase in antioxidative enzyme expression and protection against ODD. (a) Western blot analysis of MCF7, MCF10A parental cells (10A(P)), MCF10A stably expressing Flag-ERb (FL-ERb) and MCF10A FL-ERb-positive cells that express stably knockeddown levels of hPMC2 (hPMC2mi). An anti-Flag antibody was used to detect FL-ERb and GAPDH is used as a loading control. (b) Cells belonging to the indicated cell lines were treated with either 0.01% ethanol or 10 nM TOT for 3 h. Lysates were analyzed for expression levels of GCSh, QR and GSTpi by western blotting. The signals were normalized to their respective GAPDH loading controls and the fold change relative to the ethanol-treated group was calculated as described in the Materials and methods. The bars indicate the average of three independent experiments and the standard error is given by the error bars. (c and d) Cells from the indicated cell lines were treated with either 0.01% ethanol (con), 50 nM E 2 or, a combination of 50 nM E 2 and 10 nM TOT for 24 h and (c) immunostained for 8-OHdG as before. The bars represent average of four independent experiments and the error bars represent the standard error. (d) The culture media was subjected to LC-MS analysis to detect the indicated metabolite levels. The bars represent the average fold change in metabolite levels relative to the ethanol-treated group and error bars represent standard error from three independent experiments. ER, estrogen receptor; LC-MS, liquid chromatography/mass spectrometry; ODD, oxidative DNA damage; QR, quinone reductase; TOT, trans-hydroxytamoxifen. lated for hPMC2 exhibited lower levels of 4-con. This could be either due to a slower conversion of 4-OHE to 4-con or increased metabolism of 4-con to form DNA adducts in the absence of hPMC2. The similar levels of E 2 -induced ODD across all three cell lines (Figure 3c) , suggest that the lower levels of 4-con observed in E 2 -treated hPMC2mi cells may not be reflective of lower levels of 4-con formation.
As a comparison, we also measured the levels of 2-hydroxyestradiol quinone conjugates (2-con). The FL-ERb cells revealed significantly higher levels of 2-con metabolite in response to E 2 treatment in comparison with the other two cell lines tested. Since the levels of 2-OHE are comparable across the cell lines, the higher levels of 2-con more likely reflects slower catabolism of the 2-con metabolite as a result of ERb expression.
More importantly, TOT treatment reduced both 4-and 2-hydroxyestradiol-quinone conjugates levels by fourfold to sixfold in FL-ERb cells, while very little or no reduction were observed in the absence of ERb (MCF10A(P) cells), or hPMC2 (FL-ERb/hPMC2mi cells). This indicated that TOT-dependent decrease in the levels of E 2 -induced quinone conjugates is dependent on the presence of ERb and hPMC2 and not on the levels of the conjugates themselves. Further, 2-OHE 2 and 4-OHE 2 (2-OHE and 4-OHE) levels were similar both in the presence and absence of TOT in all three cell lines, indicating that the reduction in the levels of 2-con and 4-con is not simply a result of lower levels of 2-OHE 2 and 4-OHE 2 in response to TOT treatment.
Collectively, these results demonstrate a strong link between the expression levels of antioxidative enzymes and levels of quinone conjugates and underscore the key roles played by ERb and hPMC2 in mediating oxidative stress responses.
Tamoxifen-mediated recruitment of the coactivators PARP-1, topoisomerase IIb and SRC-1 to the EpRE, is dependent on both ERb and hPMC2 TOT treatment resulted in the recruitment of an ERalike activation complex at the EpRE that included both ERa and ERb (Figure 2 ). However, our previous studies indicate that TOT-ERa alone does not significantly induce antioxidative gene expression but TOT-ERb induces the expression even in the absence of ERa (Montano et al., 2004) . Hence, we analyzed the E 2 -and TOT-dependent recruitment of the ERb, hPMC2, Nrf2 and ERa-associated coactivators to the EpRE region, in MCF10A FL-ERb cells (Figures 4a and b) . We observed TOT-dependent recruitment of Nrf2, ERb, hPMC2, PARP-1, topoisomerase IIb and SRC-1, indicating that the absence of ERa does not significantly affect the recruitment of coactivators. However, induction levels of antioxidative genes by TOT in MCF7 and MCF10A FL-ERb cells are comparable (Supplementary Figure 1D and Figure 3b ), suggesting that ERa recruitment is unlikely to be a major contributor to ERb-dependent induction of EpRE promoters. In the absence of either ERb or hPMC2, we observed little or no recruitment of the factors tested, except for Nrf2. This indicates a dependence on both ERb and hPMC2 for TOT-mediated recruitment of the coactivator complex at the EpRE.
The above results taken together confirms our observations in MCF7 cells (Figure 2 ) that ERb and hPMC2 are capable of assembling an E 2 -liganded ERa-like transcription activation complex at the EpRE in response to TOT. More importantly, this result is not cell line-specific and demonstrates that ERb can assemble a functional ERa-like transcriptional complex in the absence of ERa. Tamoxifen-dependent transcription of EpRE genes SP Sripathy et al PARP-1 is involved in tamoxifen-mediated increase of antioxidative enzyme expression PARP-1 and topoisomerase IIb together are required for E 2 -dependent activation by ERa and only PARP-1 is recruited by TOT-ERa resulting in the repression (Ju et al., 2006) . However, we observe a TOT-dependent corecruitment of PARP-1 and topoisomerase IIb along with hPMC2 and ERb (Figures 2 and 4) . To investigate the functional relevance of PARP-1 recruitment in the induction of EpRE-regulated genes, we transiently downregulated PARP-1 expression by siRNA transfection in MCF10A FL-ERb cells (Figure 5a ). The downregulation of PARP-1 resulted in >50% decrease in the ability of TOT to induce the antioxidative enzymes GCSh, QR and GSTpi (Figure 5b ). Similar results were obtained by four different siRNA oligos, targeted against different regions of PARP-1 mRNA, indicating that the result is unlikely to be an off targeteffect (data not shown). The basal expression levels of GCSh, QR and GSTpi were comparable in both siRNAtransfected and control cells (Supplementary Figure 3) , indicating that the enzyme expression levels in TOTtreated samples were not the consequence of a general decrease in protein expression. This observation, along with TOT-dependent recruitment to the EpRE, suggests an important role for PARP-1 in ERb-mediated induction of antioxidative genes.
Discussion
Our studies demonstrate a TOT-dependent, localized co-recruitment of the transcription factors ERb, hPMC2, PARP-1, topoisomerase IIb, SRC-1, ERa and Nrf2 to the EpRE. Recruitment of the entire complement of coactivators is observed both in the presence and absence of ERa. More importantly, except for Nrf2, recruitment of all other coactivators is dependent on the presence of both ERb and hPMC2. Together, our data indicate TOT-dependent targeting of ERb and hPMC2 to the EpRE, with subsequent recruitment of other transcriptional regulators to form a coactivator complex resulting in transcriptional induction. The key roles played by ERb and hPMC2 are highlighted by our observations that the lack of either of these factors results in an almost complete loss of (1) TOT-induced antioxidative gene expression, (2) TOT-dependent decrease in the levels of catechol estrogen quinones and (3) protection against E 2 -induced ODD by TOT. Transcriptional induction by ERb and hPMC2 at least in part is dependent upon PARP-1 recruitment, as downregulation of PARP-1 expression results in attenuated induction of antioxidative genes by TOT. However, our observations do not support a significant role for ERa and Nrf2 in TOT-ERbmediated transcription at the EpRE. We verified induced transcription of the EpREregulated genes NQO1, GCSH and GSTP1 in MCF7 breast epithelial cells (Supplementary Figure 1) . This induction exhibited a strong correlation with the ability of TOT to protect against E 2 -induced ODD, as evidenced by the fact that the absence of either ERb or hPMC2 results in the loss of both TOT-dependent gene induction and also protection against E 2 -induced ODD after TOT treatment (Figures 1b and 3) . The EpRE-transcription factor Nrf2 is required for basal transcription of EpRE genes and induces EpRE promoters in response to high levels of oxidative stress (Ramos-Gomez et al., 2001) . Accordingly, we observed constitutive localization of Nrf2 at the EpRE ( Figures  2a, b, 4a and b) However, in the absence of either ERb or hPMC2, Nrf2 was insufficient by itself to induce antioxidative genes, or protect against E 2 -induced ODD (Figures 1b and 3) , indicating that it does not contribute significantly to TOT-ERb-mediated regulation of EpRE. A similar observation is true for ERa, even though ERa is recruited to the EpRE in a TOTdependent manner. FL-ERb cells lacking ERa expression revealed effective TOT-dependent antioxidative enzyme induction and were protected against E 2 -induced ODD by TOT (Figure 3 ). This observation is also supported by our previous findings where TOTERa did not significantly induce the transcription of EpRE-regulated reporter genes (Montano et al., 1998) . TOT treatment alone was insufficient to prevent MCF10A cells from acquiring tumorigenicity upon exposure to E 2 (Montano et al., 2007) . Also, exogenous expression of ERb, not ERa, inhibited the tumorigenic potential of E 2 in the presence of TOT (Montano et al., 2007) .
Analysis of the mechanistic basis of ERb and hPMC2 functions yielded a constitutive interaction between ERb and hPMC2 (Figure 1c) . We observe simultaneous recruitment of both ERb and hPMC2 to the EpRE when both of them are expressed, but little or no recruitment of either protein in the absence of the other (Figures 2e and 4c) . These results suggest the recruitment of an ERb-hPMC2 complex to the EpRE. ERbhPMC2 interaction is constitutive (Figure 1c) , while recruitment to the EpRE is TOT-dependent (Figures 2a  and 4a ). An explanation is that while the presence or absence of a ligand does not affect the interaction between ERb and hPMC2, it could affect the conformation of the ERb-hPMC2 complex. This could in turn result in differential recruitment of ERb and hPMC2 to target sequences in response to different ligands. This explanation seems more likely when we consider the recruitment of ERb and hPMC2 to the ERE region of the pS2 gene. ChIP analysis in MCF10A FL-ERb cells revealed recruitment of ERb and hPMC2 to the ERE under both E 2 and TOT treatments ( Supplementary  Figure 2) , in contrast to the predominantly TOTdependent recruitment observed at EpRE sequences.
Transcriptional induction at the EpRE by the TOTERb-hPMC2 pathway involves a coactivator complex very similar to that of E 2 -ERa (Figures 2a and b) , but independent of ERa recruitment (Figures 4a and b ). An explanation is that even though both ERa and ERb are recruited to the EpRE, only TOT-ERb recruitment results in transcriptional induction. In fact, studies on ligand-dependent recruitment to both classical and nonclassical ER response genes indicate that the ability of either ERa or ERb to activate transcription is not solely dependent on their recruitment to DNA, but also depend on both the ligand and the promoter context (Paech et al., 1997; Routledge et al., 2000; Wong et al., 2001; Matthews and Gustafsson, 2003; Chang et al., 2006; Matthews et al., 2006) . TOT-dependent corecruitment of ERa and ERb to the EpRE (Figure 2e ), suggests the possibility of an ERa-ERb heterodimer. It has been shown that ERa and ERb form functional heterodimers and that the heterodimer form predominates when both isoforms are expressed (Pettersson et al., 1997) . Alternately, the presence of ERa could be a consequence of protein-protein interactions with the coactivators recruited to the EpRE.
We observe increased recruitment of Nrf2 in response to TOT (Figures 2a and 4a ). This can be explained by considering both in vitro (Montano et al., 2004) and in vivo (Figure 2e ) data that indicate corecruitment of Nrf2 with ERb and hPMC2. Such an interaction can potentially result in more stable binding of Nrf2-EpRE or indirect recruitment of Nrf2 by the ERb-coactivator complex. Even though Nrf2 is required for transcription of EpRE-regulated genes, TOT treatment neither increases antioxidative enzyme levels nor inhibits E 2 -induced ODD in the absence of ERb or hPMC2 (Figure 3 ). This indicates that the ODD protective effect of TOT is primarily mediated by ERb and hPMC2, as Nrf2 alone is insufficient to induce antioxidative gene expression in response to TOT.
Finally, both PARP-1 and topoisomerase IIb are corecruited to the EpRE in response to TOT (Figures 2a, e and 4a) . It has been proposed that E 2 -ERa recruitment switches promoter occupancy from PARP-1 to PARP-1/topoisomerase IIb complex, resulting in gene activation (Lis and Kraus, 2006) . Such a scenario would explain the presence of PARP-1 at the estrogen receptor response element (ERE) region in response to TOT treatment (Supplementary Figure 2) . However, at the EpRE region, we do not observe PARP-1/topoisomeasre IIb recruitment in the absence of either ERb or hPMC2 (Figure 4c ). It is possible that PARP-1 is recruited subsequent to ERb and hPMC2, but plays a role in recruiting other coactivators by protein-protein interaction. Such a role for PARP-1 is shown to be necessary for transcription from RARb2 promoters (Pavri et al., 2005) . Even though PARP-1 is localized to the promoters of many actively transcribing genes, knockdown of PARP-1 does not affect the transcription of all the genes (Krishnakumar et al., 2008) , indicating that mere recruitment does not indicate a functional role. In this regard, our observation that the downregulation of PARP-1 attenuates TOT-dependent induction of EpRE promoters coupled with TOTdependent PARP-1/topoisomerase IIb recruitment to the EpRE underscores the contribution of PARP-1 in mediating oxidative stress responses through the TOTERb pathway.
In conclusion, our data provide a mechanistic basis for the protective effect of TOT against E 2 -induced DNA damage. We show that the protective effect of TOT is primarily mediated by ERb and hPMC2. This is significant given that ERb expression is increasingly being recognized as a positive prognostic factor for tamoxifen treatment, especially in ERa-negative breast cancers (Gruvberger-Saal et al., 2007; Speirs and Walker, 2007) . Our studies imply an important role for hPMC2 in mediating chemoprevention against breast cancer. Not much is known about the biological role of this protein apart from its ability to increase transcription from EpRE promoters in response to tamoxifen. The C-terminus of hPMC2 encodes a putative exonuclease domain (ExoIII), while in vitro data suggest that that interaction with ERb is mediated through the N-terminal (unpublished data). We can speculate that the transcriptional regulation by ERb and hPMC2 could potentially involve double-strand DNA breaks induced by the exonuclease activity and subsequent recruitment of multifunctional proteins such as PARP-1. However, further studies are required to identify the biological functions of this protein. Nevertheless, our characterization of the mechanism of transcriptional regulation by antiestrogen-ERb and identification of key players in this pathway will help us devise new strategies to prevent breast cancer progression.
Materials and methods

Plasmids
The construction of pCMV--Flag-ERb has been described previously (Montano et al., 1998) . pSuper-QRshRNA and pSuper-hPMC2shRNA were constructed by annealing to its complement, an oligonucleotide that specifies a 19 nucleotides sequence derived from the NQO1 and hPMC2 genes, respectively, and separated by a short spacer from the reverse complement of the same 19 nucleotide sequence. Oligonucleotides were ligated to the pSUPER vector (Brummelkamp et al., 2002) . To make pcDNA-hPMC2 569miR, the oligos encoding the miRNA sequences were annealed and cloned into the pcDNA 6.2 GW/EmGFP vector (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instruction. The miRNA sequences used to construct the plasmids are listed in Supplementary Table 1 .
Tissue culture and retroviral transfection Breast epithelial cells (MCF7 and MCF10A) and PA317 amphotropic packaging cells were obtained from American Type Culture Collection (Manassas, VA, USA) and maintained according to their recommended protocols. Retroviruses were made by transfecting PA317 cells with the pSuper plasmid, pSuper-hPMC2shRNA or pSuper-QRshRNA. MCF7 cells were infected with retrovirus as described previously (Bianco et al., 2003) . For all experiments, breast epithelial cells were depleted of estrogen by growth in improved minimal essential media minus phenol red containing 5% charcoal-dextran treated calf serum for 5 days before ligand treatment. Twenty-four hours postinfection cells were treated with the indicated ligands for 24 h, and processed either for western blot analysis or immunostaining.
RNA extraction and semiquantitative reverse transcriptase-PCR RNA was extracted from MCF7 cells and total mRNA was analyzed by reverse transcriptase-PCR as described in the Supplementary Methods. The primer sequences used are listed in Supplementary Table 2 .
Generation of stable MCF10A cell lines MCF10A FL-ERb cell line was generated by transfecting MCF10A human breast epithelial cells with pCMV-Flag-ERb using FuGene HD Transfection Reagent (Roche, Indianapolis, IN, USA). Cells were selected on growth media containing 500 mg/ml G418 and resistant colonies were isolated and expanded. Positive colonies were identified by western blot analysis of FL-ERb expression.
To generate MCF10A Fl-ERb/hPMC2mi cell line, MCF10A FL-ERb cells were transfected with pcDNA-hPMC2 569miR, and stable transfectants cells were selected by growing cells in the presence of 5 mg/ml blasticidin. The cells were allowed to reach 70% confluency and were then flow sorted for green fluorescent protein (GFP) expression. Knockdown of hPMC2 expression was confirmed by western blot analysis.
Immunostaining for 8-OHdG MCF7 and MCF10A cells grown on coverslips were processed further for immunostaining with anti-8-OHdG antibody as described in the Supplementary Methods.
Endogenous. immunoprecipitation and western blot analysis
Cell lysates were subjected to immunoprecipitation and the eluates were analyzed by western blotting as described in the Supplementary Methods.
Chromatin immunoprecipitation
Cells fixed with 1% formaldehyde were processed further for immunoprecipitation of the chromatin using various antibodies as described in the Supplementary Methods. The primer sequences used are listed in Supplementary Liquid chromatography/mass spectrometry analysis of E 2 metabolites Cells were treated with either 50 nM E 2 alone or together with 10 nM TOT for 24 h. The media was collected and subjected to liquid chromatography/mass spectrometry analysis to detect levels of the indicated metabolites as described by (Montano et al., 2007) . The amount of each metabolite was normalized to the total number of cells and the resulting values were used to calculate the fold change. Fold change in metabolite levels for each cell line was calculated as the ratio of the normalized value from ligand-treated sample to that of its corresponding ethanol-treated cell line.
Transient siRNA transfection Cells were maintained on stripped serum media 2 days before transfection. Trypsinized cells were then independently transfected with four different double-stranded siRNA oligos from Qiagen (Valencia, CA, USA) targeted along the PARP-1 mRNA. The transfections were carried out using siPORT amine reagent from Ambion (Austin, TX, USA) as per the reverse transfection protocol provided by the manufacturer. After 72 h, both transfected and nontransfected cells were treated with 0.01% ethanol (control) or 10 nM TOT for 3 h. Cells were harvested in phosphate-buffered saline (PBS) and whole cell lysates were analyzed by western blotting to determine the protein expression levels.
